https://www.indianpharmapost.com/alkem-laboratories-pat-at-rs-46812-crore-for-q1fy22-99232021-08-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/metropolis-healthcare-pat-at-rs-7489-crores-for-q1fy22-99242021-08-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/strides-pharma-reports-q1fy22-consolidated-loss-at-rs-2052-cr-99252021-08-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbott-india-net-profit-rises-to-85-per-cent-in-q1fy22-99262021-08-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/take-divests-stake-in-navitas-life-sciences-to-hig-99272021-08-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/cipla-posts-net-profit-at-rs-715-crores-99282021-08-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/divis-labs-posts-a-13-per-cent-rise-in-pat-at-rs-55711-crore-99292021-08-08T00:00:00+05:30always0.9